Ascend Wellness Q1 net revenue $116.9M, net loss $29.5M, Adj EBITDA $26.3M

Ascend Wellness Holdings, Inc.

Net revenue of $116.9M, down 3% sequentially from Q4 2025; retail $83.1M, wholesale $33.8M.
Net loss narrowed to $29.5M from $48.7M in Q4 2025; Adj EBITDA $26.3M (22.5% margin).
Added 5 dispensaries YTD; total 51 locations; targeting at least 60 by year end.
Michigan facility to temporarily suspend operations in late Q2 2026 for fire remediation.
Q2 2026 guidance: revenue expected +2-3% sequentially; Adj EBITDA margin low-20% range.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Ascend Wellness Holdings, Inc. reported the quarter ended March 31, 2026 results: revenue $116.9 million.

Period: the quarter ended March 31, 2026
Revenue: $116.9 million
Result: reported results

Exact text from the filing

expressly incorporated by specific reference in such filing. --- EX-99.1 (EX-99.1) --- AWH Reports First Quarter 2026 Financial Results Generated Q1 2026 net revenue of $116.9 million and Adjusted EBITDA 1 of $26.3 million 51-location footprint to date, with five dispensaries added in 2026 2 Ranked No. 2 brand house in Illinois, Massachusetts, and New Jersey

View on SEC.gov

Browse all earnings releases →

Ascend Wellness Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-034616

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.